Research ArticleArticle
Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity
Chamaida Plasencia, Eva L. Kneepkens, Gertjan Wolbink, Charlotte L.M. Krieckaert, Samina Turk, Victoria Navarro-Compán, Merel L’Ami, Mike T. Nurmohamed, Irene van der Horst-Bruinsma, Teresa Jurado, Cristina Diego, Gema Bonilla, Alejandro Villalba, Diana Peiteado, Laura Nuño, Desiree van der Kleij, Theo Rispens, Emilio Martín-Mola, Alejandro Balsa and Dora Pascual-Salcedo
The Journal of Rheumatology September 2015, 42 (9) 1638-1646; DOI: https://doi.org/10.3899/jrheum.141128
Chamaida Plasencia
From the La Paz University Hospital, and the Rheumatology Department, La Paz University Hospital-Idipaz, Madrid, Spain; Sanquin Diagnostic Services; Department of Rheumatology, VU University Medical Centre; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam; Jan van Breemen Research Institute|Reade, Amsterdam,
the Netherlands.
Eva L. Kneepkens
Gertjan Wolbink
Charlotte L.M. Krieckaert
Samina Turk
Victoria Navarro-Compán
Merel L’Ami
Mike T. Nurmohamed
Irene van der Horst-Bruinsma
Teresa Jurado
Cristina Diego
Gema Bonilla
Alejandro Villalba
Diana Peiteado
Laura Nuño
Desiree van der Kleij
Theo Rispens
Emilio Martín-Mola
Alejandro Balsa
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 42, Issue 9
1 Sep 2015
Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity
Chamaida Plasencia, Eva L. Kneepkens, Gertjan Wolbink, Charlotte L.M. Krieckaert, Samina Turk, Victoria Navarro-Compán, Merel L’Ami, Mike T. Nurmohamed, Irene van der Horst-Bruinsma, Teresa Jurado, Cristina Diego, Gema Bonilla, Alejandro Villalba, Diana Peiteado, Laura Nuño, Desiree van der Kleij, Theo Rispens, Emilio Martín-Mola, Alejandro Balsa, Dora Pascual-Salcedo
The Journal of Rheumatology Sep 2015, 42 (9) 1638-1646; DOI: 10.3899/jrheum.141128
Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity
Chamaida Plasencia, Eva L. Kneepkens, Gertjan Wolbink, Charlotte L.M. Krieckaert, Samina Turk, Victoria Navarro-Compán, Merel L’Ami, Mike T. Nurmohamed, Irene van der Horst-Bruinsma, Teresa Jurado, Cristina Diego, Gema Bonilla, Alejandro Villalba, Diana Peiteado, Laura Nuño, Desiree van der Kleij, Theo Rispens, Emilio Martín-Mola, Alejandro Balsa, Dora Pascual-Salcedo
The Journal of Rheumatology Sep 2015, 42 (9) 1638-1646; DOI: 10.3899/jrheum.141128